Trends in Molecular Medicine

Papers
(The TQCC of Trends in Molecular Medicine is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies323
Impact of the Natural Compound Urolithin A on Health, Disease, and Aging209
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease208
Ferroptosis in the tumor microenvironment: perspectives for immunotherapy171
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA163
Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome159
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis133
Ferroptosis in Parkinson’s disease: glia–neuron crosstalk124
Skin senescence: mechanisms and impact on whole-body aging112
Metabolic Pathways That Control Skin Homeostasis and Inflammation108
Enhancers in disease: molecular basis and emerging treatment strategies107
Targeting Ferroptosis: New Hope for As-Yet-Incurable Diseases93
COVID-19 in pregnancy: implications for fetal brain development85
The gut vascular barrier: a new player in the gut–liver–brain axis83
Microbiota and sleep: awakening the gut feeling79
Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment77
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation77
Extracellular matrix-based cancer targeting76
Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue72
Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines63
Circular RNA translation: novel protein isoforms and clinical significance63
Preimplantation Genetic Testing for Aneuploidy – a Castle Built on Sand61
Fibroblast Heterogeneity in Wound Healing: Hurdles to Clinical Translation61
HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease58
Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery55
FSP1: a key regulator of ferroptosis54
Tooth Repair and Regeneration: Potential of Dental Stem Cells54
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health53
Mitochondria as Therapeutic Targets in Transplantation52
Polyhydroxyalkanoates and their advances for biomedical applications52
The Ground Zero of Organismal Life and Aging52
Journey to the Center of the Cell: Tracing the Path of AAV Transduction51
Towards Advanced iPSC-based Drug Development for Neurodegenerative Disease47
Staging of Alzheimer’s disease: past, present, and future perspectives46
Homeostatic maintenance of the lymphatic vasculature46
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?46
The physiology of bilirubin: health and disease equilibrium45
Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies44
Intercellular Communication in the Heart: Therapeutic Opportunities for Cardiac Ischemia44
Single extracellular vesicle analysis for early cancer detection43
IBD disease-modifying therapies: insights from emerging therapeutics42
Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease41
Adeno-Associated Virus Vector for Central Nervous System Gene Therapy39
Trained immunity-related vaccines: innate immune memory and heterologous protection against infections39
Intestinal mucus barrier: a missing piece of the puzzle in food allergy39
Translational Neuroendocrinology of Human Skin: Concepts and Perspectives39
Cancer driver mutations: predictions and reality39
Inflammasomes and Cell Death: Common Pathways in Microparticle Diseases38
JAK–STAT Targeting Offers Novel Therapeutic Opportunities in Sepsis38
Differential Markers of Bacterial and Viral Infections in Children for Point-of-Care Testing37
N6-methyladenosine-mediated gene regulation and therapeutic implications36
Moyamoya disease emerging as an immune-related angiopathy35
PD-L1 regulation revisited: impact on immunotherapeutic strategies35
Wound Repair, Scar Formation, and Cancer: Converging on Activin35
Adolescent PCOS: a postpubertal central obesity syndrome34
The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-234
The Urgency of Justice in Research: Beyond COVID-1934
Organoid models: assessing lung cell fate decisions and disease responses34
Extracellular Vesicles and Biomaterial Design: New Therapies for Cardiac Repair33
Can’t handle the stress? Mechanobiology and disease32
Understanding human health through metatranscriptomics32
Cancer Surgery 2.0: Guidance by Real-Time Molecular Technologies32
AAV capsid design: A Goldilocks challenge32
Extinguishing the Embers: Targeting AML Metabolism32
Therapeutic potential of interleukin-2 in autoimmune diseases31
Data-Driven Modeling of Pregnancy-Related Complications31
Circadian molecular clock disruption in chronic pulmonary diseases31
Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors31
Molecular pathology of rare progeroid diseases30
Alternative Polyadenylation in Stem Cell Self-Renewal and Differentiation30
Clinical Potential of Kisspeptin in Reproductive Health29
Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging29
Dysfunctional tRNA reprogramming and codon-biased translation in cancer28
Delaying Reproductive Aging by Ovarian Tissue Cryopreservation and Transplantation: Is it Prime Time?28
New insights into vitamin K biology with relevance to cancer28
ABC transporters: human disease and pharmacotherapeutic potential27
Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges27
The global human gut microbiome: genes, lifestyles, and diet27
Helicobacter pylori-induced NF-κB: trailblazer for gastric pathophysiology27
PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies26
Sirtuins: To Be or Not To Be in Diabetic Cardiomyopathy26
T Cells as Guardians of Pain Resolution25
It’s in Our Blood: A Glimpse of Personalized Medicine25
Influenza A Viruses: Understanding Human Host Determinants25
Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes24
Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy24
Pulmonary fibrosis: from pathogenesis to clinical decision-making24
Treatment and Prevention of Neurocristopathies24
Role and therapeutic implications of protein glycosylation in neuroinflammation24
Organoid technologies for the study of intestinal microbiota–host interactions24
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines24
Readthrough compounds for nonsense mutations: bridging the translational gap24
Exposing the role of metals in neurological disorders: a focus on manganese23
Breakthroughs and Bottlenecks in Microbiome Research23
Targeting synaptic plasticity in schizophrenia: insights from genomic studies23
Adenoviruses in medicine: innocuous pathogen, predator, or partner23
Multivalent Probes in Molecular Imaging: Reality or Future?22
Pathogenic associations between oral and gastrointestinal diseases22
A map of the altered glioma metabolism22
Linking liver metabolic and vascular disease via bile acid signaling22
Post-Transcriptional Regulation in Skeletal Muscle Development, Repair, and Disease22
Redefining Microglial Identity in Health and Disease at Single-Cell Resolution22
mRNA therapeutics: beyond vaccine applications21
Brain gene therapy with Trojan horse lipid nanoparticles21
Breakthroughs and bottlenecks in autophagy research21
The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis21
Topical Microbial Therapeutics against Respiratory Viral Infections21
Bridging rapid and sustained antidepressant effects of ketamine21
The ubiquitin–proteasome system in breast cancer21
Maternal obesity: new placental paradigms unfolded21
Epigenetic regulation in intervertebral disc degeneration21
Fibroblasts in pancreatic cancer: molecular and clinical perspectives20
Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance20
Historical Perspective of Clinical Nano and Microparticle Formulations for Delivery of Therapeutics20
Ectopic Lymphoid Organs and Immune-Mediated Diseases: Molecular Basis for Pharmacological Approaches19
iPSCs and DRGs: stepping stones to new pain therapies19
Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis18
How aging impacts vaccine efficacy: known molecular and cellular mechanisms and future directions18
COVID-19 vaccines in pregnancy18
Clock-modulated checkpoints in time-restricted eating18
The spike hypothesis in vaccine-induced adverse effects: questions and answers18
Organoids, Where We Stand and Where We Go18
Predicting and Overcoming Taxane Chemoresistance18
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease18
Dietary interventions and precision nutrition in cancer therapy18
Mining Helminths for Novel Therapeutics17
Stratum corneum as polymer sheet: concept and cornification processes17
ROS/RNS as molecular signatures of chronic liver diseases17
Role of inflammasomes in HIV-1 infection and treatment17
Unlocking the potential of agonist antibodies for treating cancer using antibody engineering17
DNA Damage Repair Deficiency and Synthetic Lethality for Cancer Treatment16
Nutrition interventions in congenital disorders of glycosylation16
Molecular disease mechanisms of human antineuronal monoclonal autoantibodies16
CGRP Receptor Antagonism in COVID-19: Potential Cardiopulmonary Adverse Effects16
Cellular senescence in neuroinflammatory disease: new therapies for old cells?16
Nasal vaccines: solutions for respiratory infectious diseases16
ERα in the Control of Mitochondrial Function and Metabolic Health16
CircRNA perspective: new strategies for RNA therapy16
Unleashing cell-penetrating peptide applications for immunotherapy16
Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia16
Future medicine: from molecular pathways to the collective intelligence of the body16
Particulate matter and Alzheimer’s disease: an intimate connection16
Cell-free circulating tumor DNA profiling in cancer management15
PIK3CA-related overgrowth: silver bullets from the cancer arsenal?15
In Utero Gene Therapy: Progress and Challenges15
Advances in Inflammasome Research: Recent Breakthroughs and Future Hurdles15
Understanding the tuberculosis granuloma: the matrix revolutions15
Erythrophagocytes in hemolytic anemia, wound healing, and cancer14
siRNA modification and delivery for drug development14
Microglia–T cell conversations in brain cancer progression14
d-Amino acids: new clinical pathways for brain diseases14
Recent insights into lysosomal acid lipase deficiency14
The microbiome, guard or threat to infant health14
Deciphering the Identity of Renin Cells in Health and Disease14
Biological principles of adult degenerative scoliosis14
NK cells in the brain: implications for brain tumor development and therapy14
Developing Novel Tests to Screen for Fetal Growth Restriction14
Polycystic kidney disease: novel insights into polycystin function14
0.066873788833618